01
Nov
Nov
Product defect correction – potential for incorrect medicine in the pack Consumers and health professionals are advised that Aspen Pharma, in consultation with the TGA, is undertaking a product defect correction for one batch of Endone 5 mg tablets (batch number CW612, expiry November 2020). A single pack of Endone 5 mg tablets in South Australia has […]